Results
1
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
1 companies
Giant Biogene Holding
Market Cap: HK$43.3b
An investment holding company, designs, develops, manufactures, and sells skin treatment products with recombinant collagen in the People’s Republic of China.
2367
HK$40.40
7D
-24.4%
1Y
-22.0%